ULILEDLIMAB

UNII:	3OX1DBR75G
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ULILEDLIMAB
GSRS Full Record:	3OX1DBR75G i

2378407-27-1
Immunoglobulin G1 [300-alanine], anti-(human CD73 antigen) (human-Mus musculus monoclonal TJ004309 γ1-chain), disulfide with human-Mus musculus monoclonal TJ004309 κ-chain, dimer
Immunoglobulin G1-kappa, anti-[Homo sapiens NT5E (5'-nucleotidase ecto, 5' nucleotidase, NT5, eN, eNT NTE, CALJA, CD73)], monoclonal antibody; gamma1 heavy chain (1-450) [VH (Homo sapiens IGHV4-38-2*01 (87.6%) -(IGHD) -IGHJ6*01 (100%)) CDR-IMGT [9.7.13] (26-34.52-58.97-109) (1-120) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 (CH1 R>K 120 (217) (121-218), hinge 1-15 (219-233), CH2 N84.4>A (300) (234-343), CH3 E12 (359), M14 (361) (344-448), CHS(449-450)) (121-450)], (223-213')-disulfide with kappa light chain (1'-215') [V-KAPPA (Mus musculus IGKV4-72*01 (81.1%) -IGKJ1*01 (90.9%) L124>V (103)/Homo sapiens IGKV3-11*01 (77.9%) -IGKJ4*01 (100%)) CDR-IMGT [5.3.9] (26-31.59-51.88-96) (1'-106') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (152), V101 (190) (107'-213')]; dimer (229-229'':232-232'')-bisdisulfide, produced in a Chinese hamster ovary (CHO)-K1 cell line, non-glycosylated
TJ-004309
TJ-D5
TJ004309
ULILEDLIMAB [USAN]
Uliledlimab [WHO-DD]
uliledlimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ULILEDLIMAB

Synonyms and Mappings

Resources